Michal Ayalon is the founder of Kamada. Backed by First Israel Mezzanine Investors, FIMI Opportunity Funds, The Phoenix Holdings Ltd..
Michal Ayalon, Ph.D. is a senior biopharmaceutical executive who currently serves as the Vice President of Research and Development at Kamada. Kamada is a plasma-derived protein therapeutics company. The company focuses on developing, manufacturing, and commercializing plasma-derived protein therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide